BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 16201508)

  • 1. [Brain glioblastoma and astrocytoma].
    Kawamoto K; Li Q; Azuma K; Ryu T; Sakurai Y
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():105-9. PubMed ID: 16201508
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased levels of p21WAF1/Cip1 in human brain tumors.
    Jung JM; Bruner JM; Ruan S; Langford LA; Kyritsis AP; Kobayashi T; Levin VA; Zhang W
    Oncogene; 1995 Nov; 11(10):2021-8. PubMed ID: 7478521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel p53/p130 axis in bladder tumors.
    Mudryj M; Reay E; Beckett L; Dandekar S; deVere White R; Gandour-Edwards R
    Urology; 2007 Sep; 70(3):608-12. PubMed ID: 17905135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors.
    Tanino M; Sasajima T; Nanjo H; Akesaka S; Kagaya M; Kimura T; Ishida Y; Oda M; Takahashi M; Sugawara T; Yoshioka T; Nishihara H; Akagami Y; Goto A; Minamiya Y; Tanaka S;
    Brain Tumor Pathol; 2015 Jan; 32(1):12-9. PubMed ID: 24807101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.
    Capper D; Sahm F; Hartmann C; Meyermann R; von Deimling A; Schittenhelm J
    Am J Surg Pathol; 2010 Aug; 34(8):1199-204. PubMed ID: 20661018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma].
    Yuge F; Hirakata H; Igarashi H; Kodama M; Kawata N; Takimoto Y
    Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
    Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
    Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers in stage P1 bladder cancer.
    Stavropoulos NE; Ioachim E; Charchanti A; Michael MC; Kitsiou E; Mihailidis I; Hastazeris K; Agnantis NJ
    Anticancer Res; 2001; 21(2B):1495-8. PubMed ID: 11396238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors.
    Mendes RA; Carvalho JF; van der Waal I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Mar; 111(3):333-9. PubMed ID: 21215666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ki-67 and p53 expressions versus differentiation degrees of colon adenocarcinoma].
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):183-90. PubMed ID: 18677924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
    Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
    Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of breast cancer in young women: prognosis and prognostic factors.
    Saito E
    Nihon Geka Hokan; 1996 Nov; 65(4):133-44. PubMed ID: 9528272
    [No Abstract]   [Full Text] [Related]  

  • 19. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
    Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
    Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression.
    Queipo-Zaragoza JA; Ruiz-Cerda JL; Vera-Donoso CD; Vera-Sempere F; Budia-Alba A; Jimenez-Cruz JF
    Scand J Urol Nephrol; 2007; 41(4):283-9. PubMed ID: 17763218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.